Study of 2'5' oligo (A) synthetase in patients with metastatic renal cell carcinoma.
Vakalikos
J
J
Dimasis
N
N
Peftulidis
S
S
Galaktidou
G
G
Kortsaris
A H
AH
D015088:2',5'-Oligoadenylate Synthetase / Q000096:biosynthesis / Q000097:blood*; D015415:Biomarkers / Q000097:blood; D002292:Carcinoma, Renal Cell / Q000097:blood / Q000201:enzymology / Q000378:metabolism* / Q000628:therapy; D004790:Enzyme Induction / Q000187:drug effects; D006801:Humans; D007155:Immunologic Factors / Q000494:pharmacology* / Q000627:therapeutic use; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000494:pharmacology* / Q000627:therapeutic use; D007680:Kidney Neoplasms / Q000097:blood / Q000628:therapy; D007963:Leukocytes, Mononuclear / Q000201:enzymology*; D011994:Recombinant Proteins; D016896:Treatment Outcome
D015415:Biomarkers; D007155:Immunologic Factors; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D015088:2',5'-Oligoadenylate Synthetase